Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Factor IX and deep vein thrombosis.

Literature DB >> 19407317

Factor IX and deep vein thrombosis.

Abstract

Elevated levels of several coagulation factors have been found to be associated with an increased risk of thrombosis. In this perspective article, Dr. Lowe examines the implications of the report by Bezemer and coworkers in this issue for our understanding of the mechanisms involved and how they should direct future research.

Entities: Disease

Mesh：

Substances：
Factor IX

Year: 2009 PMID： 19407317 PMCID： PMC2675672 DOI： 10.3324/haematol.2009.005769

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

18 in total

Review 1. Factor IX and thrombosis.

Authors: G D Lowe
Journal: Br J Haematol Date: 2001-12 Impact factor: 6.998

Review 2. Mendelian randomization: prospects, potentials, and limitations.

Authors: George Davey Smith; Shah Ebrahim
Journal: Int J Epidemiol Date: 2004-02 Impact factor: 7.196

3. F9 Malmö, factor IX and deep vein thrombosis.

Authors: Irene D Bezemer; Andre R Arellano; Carmen H Tong; Charles M Rowland; Helen A Ireland; Kenneth A Bauer; Joseph Catanese; Pieter H Reitsma; Carine J M Doggen; James J Devlin; Frits R Rosendaal; Lance A Bare
Journal: Haematologica Date: 2009-03-13 Impact factor: 9.941

4. von Willebrand factor and coronary heart disease: prospective study and meta-analysis.

Authors: P H Whincup; J Danesh; M Walker; L Lennon; A Thomson; P Appleby; A Rumley; G D O Lowe
Journal: Eur Heart J Date: 2002-11 Impact factor: 29.983

5. Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use.

Authors: G D Lowe; A Rumley; M Woodward; C E Morrison; H Philippou; D A Lane; H Tunstall-Pedoe
Journal: Br J Haematol Date: 1997-06 Impact factor: 6.998

6. Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease.

Authors: M Woodward; G D Lowe; A Rumley; H Tunstall-Pedoe; H Philippou; D A Lane; C E Morrison
Journal: Br J Haematol Date: 1997-06 Impact factor: 6.998

7. Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy.

Authors: G Lowe; M Woodward; M Vessey; A Rumley; P Gough; E Daly
Journal: Thromb Haemost Date: 2000-04 Impact factor: 5.249

8. High levels of factor IX increase the risk of venous thrombosis.

Authors: A van Hylckama Vlieg; I K van der Linden; R M Bertina; F R Rosendaal
Journal: Blood Date: 2000-06-15 Impact factor: 22.113

9. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE).

Authors: Albert W Tsai; Mary Cushman; Wayne D Rosamond; Susan R Heckbert; Russell P Tracy; Nena Aleksic; Aaron R Folsom
Journal: Am J Med Date: 2002-12-01 Impact factor: 4.965